title: Adverse effects of FK 506 overdosage after liver transplantation.
authors.affiliation: Transplant Institute of Pittsburgh, PA 15213.
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: U
authors.initials: U
authors.lastname: Cillo
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: W
authors.initials: W
authors.lastname: Irish
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: D
authors.initials: D
authors.lastname: Van Thiel
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000206:Actuarial Analysis; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D007677:Kidney Function Tests; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D011188:Potassium / Q000097:blood; D016559:Tacrolimus / Q000097:blood / Q000633:toxicity*
chemical_list: D011188:Potassium; D016559:Tacrolimus